Home › Funds › Mawer Investment Management Ltd. › ABT

Mawer Investment Management Ltd. position in ABT

ABBOTT LABORATORIES · Health Care

Mawer Investment Management Ltd. reported holding 1,118,031 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$110.5M, representing 0.81% of its reported portfolio and ranking #32 among its reported holdings. Mawer Investment Management Ltd. has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.12M sh
Reported value held$110.50M
Portfolio Weight0.81%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Mawer Investment Management Ltd.'s ABT position evolved

Mawer Investment Management Ltd. first disclosed a stake in ABT in Q3 2023 at 1,037,218 shares (US$100.5M). The position peaked in Q1 2025 at 1,311,221 shares, worth US$173.9M. Across 13 filings, Mawer Investment Management Ltd. increased the stake 3 time(s), trimmed it 9 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,118,031 shares valued at US$110.5M — a reduction of -68,646 shares quarter over quarter.. Notable position changes include a 48% increase in Q4 2023 (shares rose 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.04M $100.45M New
Q4 2023 1.54M $169.09M Add
Q1 2024 1.45M $165.20M Reduce
Q2 2024 1.42M $147.99M Reduce
Q3 2024 1.40M $159.59M Reduce
Q4 2024 1.36M $153.39M Reduce
Q1 2025 1.31M $173.93M Reduce
Q2 2025 1.19M $161.26M Reduce
Q3 2025 1.26M $168.20M Add
Q4 2025 1.25M $156.04M Reduce
Q1 2026 1.25M $128.72M Add
Q2 2026 1.19M $107.68M Reduce
Q3 2026 1.12M $110.50M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Mawer Investment Management Ltd. held ABT?

Mawer Investment Management Ltd. has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Mawer Investment Management Ltd.'s current position in ABT?

As of Q3 2026, Mawer Investment Management Ltd. holds 1.12M shares of ABT (ABBOTT LABORATORIES), valued at $110.50M, representing 0.81% of its reported portfolio and ranking #32.

Has Mawer Investment Management Ltd. been buying or selling ABT?

In the latest 13F filing (Q3 2026), Mawer Investment Management Ltd. reduced its position in ABT. The position peaked in Q1 2025 at 1.31M shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.